Study of Olaparib Maintenance Following Cabazitaxel-Carbo in Men With AVPC

NCT03263650 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

96

Enrollment

OTHER

Sponsor class

Conditions

Prostate Cancer Aggressiveness
Prostate Carcinoma

Interventions

DRUG: Cabazitaxel
DRUG: Carboplatin
DRUG: Prednisone 5Mg
DRUG: Olaparib

Sponsor

M.D. Anderson Cancer Center

Collaborators

[object Object]
[object Object]